Fulton Bank, N.A. Amgen Inc Transaction History

Fulton Bank, N.A.

$1.19 Billion
Q3 2024

A detailed history of Fulton Bank, N.A. transactions in Amgen Inc stock. As of the latest transaction made, Fulton Bank, N.A. holds 15,737 shares of AMGN stock, worth $4.45 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

15,737

Previous 17,914 12.15%

Holding current value

$4.45 Million

Previous $5.6 Million 9.42%

% of portfolio

0.43%

Previous 0.5%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$309.38 - $337.38 $673,520 - $734,476	-2,177 Reduced 12.15%	15,737 $5.07 Million
Q2 2024 Jul 09, 2024	BUY	$262.75 - $319.31 $1.54 Million - $1.88 Million	5,880 Added 48.86%	17,914 $5.6 Million
Q1 2024 Apr 10, 2024	SELL	$268.87 - $324.56 $822,473 - $992,829	-3,059 Reduced 20.27%	12,034 $3.42 Million
Q4 2023 Jan 04, 2024	SELL	$255.7 - $288.46 $472,789 - $533,362	-1,849 Reduced 10.91%	15,093 $4.35 Million
Q3 2023 Oct 04, 2023	BUY	$218.65 - $271.46 $22,958 - $28,503	105 Added 0.62%	16,942 $4.55 Million
Q2 2023 Jul 06, 2023	BUY	$214.27 - $253.37 $1.36 Million - $1.6 Million	6,329 Added 60.23%	16,837 $3.74 Million
Q1 2023 Apr 06, 2023	BUY	$225.79 - $275.2 $27,546 - $33,574	122 Added 1.17%	10,508 $2.54 Million
Q4 2022 Jan 05, 2023	SELL	$229.03 - $291.01 $1.18 Million - $1.5 Million	-5,144 Reduced 33.12%	10,386 $2.73 Million
Q3 2022 Oct 04, 2022	BUY	$224.46 - $253.15 $514,462 - $580,219	2,292 Added 17.31%	15,530 $3.5 Million
Q2 2022 Jul 07, 2022	SELL	$230.71 - $256.74 $72,442 - $80,616	-314 Reduced 2.32%	13,238 $3.22 Million
Q1 2022 Apr 05, 2022	SELL	$219.27 - $242.57 $834,103 - $922,736	-3,804 Reduced 21.92%	13,552 $3.28 Million
Q4 2021 Jan 05, 2022	BUY	$198.88 - $227.6 $597,435 - $683,710	3,004 Added 20.93%	17,356 $3.9 Million
Q3 2021 Oct 05, 2021	SELL	$212.27 - $248.7 $939,294 - $1.1 Million	-4,425 Reduced 23.57%	14,352 $3.05 Million
Q2 2021 Jul 06, 2021	SELL	$233.58 - $259.14 $256,938 - $285,054	-1,100 Reduced 5.53%	18,777 $4.58 Million
Q1 2021 Apr 05, 2021	BUY	$221.91 - $258.6 $172,202 - $200,673	776 Added 4.06%	19,877 $4.95 Million
Q4 2020 Jan 07, 2021	BUY	$216.38 - $257.67 $187,817 - $223,657	868 Added 4.76%	19,101 $4.39 Million
Q3 2020 Oct 06, 2020	BUY	$234.65 - $260.95 $71,568 - $79,589	305 Added 1.7%	18,233 $4.63 Million
Q2 2020 Jul 06, 2020	BUY	$197.81 - $242.74 $116,905 - $143,459	591 Added 3.41%	17,928 $4.23 Million
Q1 2020 Apr 03, 2020	BUY	$182.24 - $241.7 $35,172 - $46,648	193 Added 1.13%	17,337 $3.52 Million
Q4 2019 Jan 24, 2020	BUY	$189.21 - $243.2 $586,361 - $753,676	3,099 Added 22.06%	17,144 $4.13 Million
Q3 2019 Oct 03, 2019	SELL	$174.11 - $208.62 $26,290 - $31,501	-151 Reduced 1.06%	14,045 $2.72 Million
Q2 2019 Jul 03, 2019	BUY	$166.7 - $195.41 $57,511 - $67,416	345 Added 2.49%	14,196 $2.62 Million
Q1 2019 Apr 03, 2019	BUY	$180.87 - $203.88 $106,532 - $120,085	589 Added 4.44%	13,851 $2.63 Million
Q4 2018 Jan 03, 2019	SELL	$178.4 - $208.25 $69,040 - $80,592	-387 Reduced 2.84%	13,262 $2.58 Million
Q3 2018 Oct 03, 2018	SELL	$185.29 - $208.89 $37,613 - $42,404	-203 Reduced 1.47%	13,649 $2.83 Million
Q2 2018 Jul 10, 2018	SELL	$166.05 - $186.51 $104,113 - $116,941	-627 Reduced 4.33%	13,852 $2.56 Million
Q1 2018 May 02, 2018	BUY	$169.43 - $198.0 $72,685 - $84,942	429 Added 3.05%	14,479 $2.47 Million
Q4 2017 Jan 04, 2018	BUY	$168.79 - $188.59 $607,137 - $678,358	3,597 Added 34.41%	14,050 $2.44 Million
Q3 2017 Oct 04, 2017	BUY	$167.29 - $191.0 $1.75 Million - $2 Million	10,453	10,453 $1.95 Million

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.

Account